Skip to main content
OpenTrials
Completed

NCT Number: NCT02242383

Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension

To evaluate efficacy and tolerability of Micardis® / MicardisPlus® under usual daily-practice prescribing conditions with a special emphasis on controlling morning blood pressure

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years, insufficiently treated hypertension

Exclusion criteria

  • Age < 18 years

Treatment and study plan

Telmisartan

Drug

Telmisartan in combination with hydrochlorothiazide

Drug

Primary outcomes

  1. Changes in morning blood pressure (BP)

    Time frame: Pre-dose, up to 6 months after start of treatment

  2. Changes in metabolic laboratory parameters

    Time frame: Pre-dose, up to 6 months after start of treatment

  3. Changes in morning blood pressure in patients with or without telemonitoring (TM) of BP

    Time frame: Pre-dose, up to 6 months after start of treatment

  4. Investigator assessment of efficacy in reducing morning hypertension on a 5-point rating scale

    Time frame: Up to 6 months after start of treatment

  5. Investigator assessment of effects on metabolism on a 3-point rating scale

    Time frame: Up to 6 months after start of treatment

  6. Investigator assessment of tolerability on a 5-point rating scale

    Time frame: Up to 6 months after start of treatment

  7. Number of patients with adverse events

    Time frame: Up to 6 months

  8. Changes in morning heart rate

    Time frame: Pre-dose, up to 6 months after start of treatment

Sponsors and collaborators

Lead sponsor

Boehringer Ingelheim

Industry

Registry information

Official study title

Morning Hypertension and Monitoring of Metabolism (AWB Morgenhochdruck & Stoffwechselmonitoring)

Important dates

Study start
2005
Primary completion
2005
First posted
Sep 17, 2014
Registry last updated
Sep 17, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.